Free Trial
ASX:COH

Cochlear (COH) Stock Price, News & Analysis

Cochlear logo

About Cochlear Stock (ASX:COH)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
201,277 shs
Average Volume
N/A
Market Capitalization
A$19.88 billion
P/E Ratio
55.90
Dividend Yield
1.35%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive COH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

COH Stock News Headlines

Cochlear earnings: Shares overvalued as demand softens
Buffett to put 90% of his money in this one stock?
CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accounting firms like Deloitte and KPMG, Joel Litman (who’s also a member of the Global CFA Institute) figured out a unique, less-risky way to grow rich in the stock market. Litman says you don’t need dozens of investments, overpriced advisers, or hedge funds. You just need these 3 stocks, which have helped Litman’s own mom earn 3,400%.tc pixel
Cochlear Limited Announces 2025 AGM Details
See More Headlines

COH Stock Analysis - Frequently Asked Questions

Cochlear Limited (ASX:COH) posted its quarterly earnings results on Tuesday, February, 19th. The company reported $2.15 EPS for the quarter, missing analysts' consensus estimates of $2.19 by $0.04. Cochlear had a trailing twelve-month return on equity of 19.70% and a net margin of 15.80%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cochlear investors own include CSL (CSL), ResMed (RMD), NIB (NHF), Accent Group (AX1), Corporate Travel Management (CTD), Mineral Resources (MIN) and Technology One (TNE).

Company Calendar

Last Earnings
2/19/2019
Today
8/30/2025
Ex-Dividend for 10/12 Dividend
9/17/2025
Record date for 10/12 Dividend
10/12/2025
Dividend Payable
10/12/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
ASX:COH
CIK
N/A
Fax
N/A
Employees
4,996
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A$5.43
Trailing P/E Ratio
55.90
Forward P/E Ratio
N/A
P/E Growth
3.87
Net Income
A$356.80 million
Net Margins
15.80%
Pretax Margin
N/A
Return on Equity
19.70%
Return on Assets
11.99%

Debt

Debt-to-Equity Ratio
13.24
Current Ratio
2.30
Quick Ratio
1.93

Sales & Book Value

Annual Sales
A$2.24 billion
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
123.45
Book Value
A$28.10 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
65,500,000
Free Float
N/A
Market Cap
A$19.88 billion
Optionable
Not Optionable
Beta
0.47
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (ASX:COH) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners